title: How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia?
abstract: An increasing emphasis in the schizophrenia literature has been on the prodromal phase of the illness. The study of schizophrenia spectrum illness, including schizotypal personality disorder, has added important insight into the etiology, neuropathology, and treatment of schizophrenia, which can facilitate early identification, intervention, and perhaps prevention of the illness. The heterogeneity of the schizophrenia spectrum makes its definition elusive at best. The primary aim of the Cognitive Assessment and Risk Evaluation Program at the authors' institution is to combine the current knowledge of clinical and demographic risk factors for schizophrenia with the rapidly emerging data on vulnerability markers, or endophenotypes, that are associated with schizophrenia. The use of brain-based vulnerability markers may help to identify neurobiologically and clinically meaningful subgroups within this heterogeneous population of individuals in the early stages of schizophrenia. Another important aim of the Cognitive Assessment and Risk Evaluation program is to thoroughly assess those individuals who have not converted to psychosis to understand potential protective factors, reduce the rate of false positives, and decrease disability. The current review details a strategy for researching the schizophrenia prodrome by using information gained from research in schizotypal personality disorder.
authors.affiliation: Department of Psychiatry, 0810, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
authors.forename: Katherine
authors.initials: K
authors.lastname: Seeber
authors.forename: Kristin S
authors.initials: KS
authors.lastname: Cadenhead
mesh_terms: D001921:Brain / Q000473:pathology; D003071:Cognition; D006801:Humans; D011569:Psychiatric Status Rating Scales; D012307:Risk Factors; D012559:Schizophrenia / Q000209:etiology* / Q000503:physiopathology; D012565:Schizophrenic Psychology; D012569:Schizotypal Personality Disorder / Q000523:psychology*; D009626:Terminology as Topic
references.citation: Biol Psychiatry. 2004 Apr 1;55(7):663-7
references.pmid: 15038993
references.citation: Arch Gen Psychiatry. 2001 Feb;58(2):158-64
references.pmid: 11177117
references.citation: Schizophr Res. 2002 Mar 1;54(1-2):177-86
references.pmid: 11853992
references.citation: Schizophr Res. 2001 Aug 1;51(1):17-29
references.pmid: 11479062
references.citation: Schizophr Res. 2004 Nov 1;71(1):97-101
references.pmid: 15374577
references.citation: Biol Psychiatry. 2003 Aug 15;54(4):453-64
references.pmid: 12915290
references.citation: Psychol Med. 2003 Oct;33(7):1239-47
references.pmid: 14580078
references.citation: J Abnorm Psychol. 1978 Aug;87(4):399-407
references.pmid: 681612
references.citation: Curr Psychiatry Rep. 2000 Oct;2(5):398-403
references.pmid: 11122987
references.citation: Schizophr Res. 2004 Sep 1;70(1):27-31
references.pmid: 15246460
references.citation: J Clin Exp Neuropsychol. 2003 May;25(3):335-47
references.pmid: 12916647
references.citation: Schizophr Res. 2001 Aug 1;51(1):31-8
references.pmid: 11479063
references.citation: Am J Med Genet. 2002 Dec 8;114(8):929-37
references.pmid: 12457389
references.citation: Schizophr Res. 2004 Apr 1;67(2-3):131-42
references.pmid: 14984872
references.citation: Schizophr Res. 1995 Sep;17(1):77-84
references.pmid: 8541253
references.citation: Schizophr Bull. 2003;29(4):703-15
references.pmid: 14989408
references.citation: Arch Gen Psychiatry. 2002 Oct;59(10):921-8
references.pmid: 12365879
references.citation: Br J Psychiatry Suppl. 2002 Sep;43:s30-7
references.pmid: 12271798
references.citation: Arch Gen Psychiatry. 2001 Jul;58(7):669-73
references.pmid: 11448374
references.citation: Schizophr Res. 2002 Mar 1;54(1-2):169-75
references.pmid: 11853991
references.citation: Am J Psychiatry. 2002 May;159(5):869-71
references.pmid: 11986147
references.citation: Psychiatry Res. 1995 Nov 29;59(1-2):127-36
references.pmid: 8771227
references.citation: Am J Psychiatry. 2002 May;159(5):863-5
references.pmid: 11986145
references.citation: J Am Acad Psychoanal Dyn Psychiatry. 2003 Spring;31(1):229-45
references.pmid: 12722897
references.citation: Schizophr Res. 2004 Apr 1;67(2-3):115-22
references.pmid: 14984870
references.citation: Psychol Rep. 2004 Apr;94(2):387-97
references.pmid: 15154161
references.citation: Acta Psychiatr Scand. 2001 May;103(5):323-34
references.pmid: 11380302
references.citation: Arch Gen Psychiatry. 2001 Oct;58(10):959-64
references.pmid: 11576035
references.citation: Neurotox Res. 2004;6(1):43-50
references.pmid: 15184104
references.citation: J Clin Psychiatry. 2003 Jun;64(6):628-34
references.pmid: 12823075
references.citation: Schizophr Res. 2004 May 1;68(1):37-48
references.pmid: 15037338
references.citation: Methods. 2002 Jul;27(3):287-99
references.pmid: 12183117
references.citation: Schizophr Res. 2004 Dec 1;71(2-3):227-37
references.pmid: 15474894
references.citation: Biol Psychiatry. 2004 May 15;55(10 ):1001-6
references.pmid: 15121484
references.citation: Psychiatry Res. 2004 Jan 1;121(3):303-7
references.pmid: 14675749
references.citation: Schizophr Bull. 2002;28(3):393-9
references.pmid: 12645672
references.citation: Am J Psychiatry. 2001 Aug;158(8):1286-90
references.pmid: 11481164
references.citation: Biol Psychiatry. 2004 Jan 15;55(2):177-84
references.pmid: 14732598
references.citation: Schizophr Bull. 2003;29(2):299-309
references.pmid: 14552505
references.citation: Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):117-28
references.pmid: 15146341
references.citation: Psychophysiology. 2004 May;41(3):367-71
references.pmid: 15102121
references.citation: Arch Gen Psychiatry. 2001 Sep;58(9):877-84
references.pmid: 11545672
references.citation: Curr Psychiatry Rep. 2004 Aug;6(4):289-95
references.pmid: 15260945
references.citation: Schizophr Bull. 2003;29(4):803-30
references.pmid: 14989416
references.citation: Schizophr Bull. 2003;29(2):285-98
references.pmid: 14552504
references.citation: Schizophr Res. 2003 Nov 1;64(1):1-13
references.pmid: 14511796
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):36-40
references.pmid: 12497611
references.citation: Curr Psychiatry Rep. 2003 Aug;5(4):311-9
references.pmid: 12857535
references.citation: Schizophr Res. 2003 Nov 1;64(1):35-9
references.pmid: 14511799
references.citation: Am J Med Genet. 2002 Dec 8;114(8):956-66
references.pmid: 12457393
references.citation: Psychiatr Clin North Am. 2002 Dec;25(4):837-53
references.pmid: 12462863
references.citation: Am J Psychiatry. 2004 Mar;161(3):398-413
references.pmid: 14992962
references.citation: Am J Psychiatry. 2003 Oct;160(10):1790-4
references.pmid: 14514492
references.citation: Schizophr Bull. 2000;26(1):119-36
references.pmid: 10755673
references.citation: Psychopharmacol Bull. 2003 Spring;37(2):79-101
references.pmid: 14566217